Evidence map›Paper›PMID 41140098›Full record

SynthesisAnnals of medicine2025

Benefits of different characteristics of pulmonary rehabilitation programs in patients with interstitial lung disease: a systematic review and meta-analysis.

Qian Chen, Yifan Qiu, Mengchun Xu, Liang Dong

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qian ChenDepartment of Respiratory, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Yifan QiuDepartment of Respiratory, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Mengchun XuDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.
Liang DongDepartment of Respiratory, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.ORCID 0000-0001-7707-9982

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInterstitial lung disease (ILD) is defined by progressive pulmonary fibrosis, restrictive ventilatory dysfunction, and hypoxemia, with significant differences in disease presentation, clinical course, and prognosis. This study aims to evaluate the clinical benefits of pulmonary rehabilitation with different characteristics in ILD patients.

methodsThis study searched electronic databases (PubMed, Embase, Web of Science, Cochrane Library, Clinical trials) and included 33 articles in a meta-analysis (1671 ILD patients). Two investigators independently appraised relevance, trial quality, and data extraction.

resultsThe meta-analysis demonstrated that pulmonary rehabilitation is effective in enhancing exercise endurance, alleviating exertional hypoxemia, and improving quality of life among ILD patients. Key outcomes (all

conclusionPulmonary rehabilitation has a positive therapeutic effect on ILD patients, significantly enhancing exercise endurance and tolerance, and improving quality of life. However, it is essential to assess the patient's condition and tailor the pulmonary rehabilitation plan to the individual to achieve the best therapeutic outcomes.

Indexed as

Exercise TherapyLung Diseases, InterstitialExercise ToleranceHumansHypoxiaQuality of LifeTreatment OutcomeWalk Test6-min walk testinterstitial lung diseasemeta-analysispulmonary rehabilitationsystematic review

Identifiers

PMID41140098
PMCPMC12570254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.